I Ye Poverennova (I E Poverennova)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 12

Top Topics

Ejection Fraction

Top Venues

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

This page only lists publications with an associated author ORCID identifier.

Publications

A N Boyko, Valentina M Alifirova, I G Lukashevich, Zoya A Goncharova, I V Greshnova, L G Zaslavsky, S V Kotov, N A Malkova, G N Mishin, Ye V Parshina, I Ye Poverennova, L N Prakhova, Stella Sivertseva, I V Smagina, N A Totolyan, Yu V Trinitatsky, T N Trushnikova, F A Khabirov, Zh Yu Chefranova, S G Shchur, V A Dudin, D V Pokhabov, A V Artemeva, Anna V Eremeeva, Yulia N Linkova, Arina V Zinkina-Orikhan
[Long-term efficacy and safety of divozilimab during 2-year treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 124 (4) (2024)
A N Boyko, Valentina M Alifirova, I G Lukashevich, Zoya A Goncharova, I V Greshnova, L G Zaslavsky, S V Kotov, N A Malkova, G N Mishin, Ye V Parshina, I Ye Poverennova, L N Prakhova, Stella Sivertseva, I V Smagina, N A Totolyan, Yu V Trinitatsky, T N Trushnikova, F A Khabirov, Zh Yu Chefranova, S G Shchur, V A Dudin, D V Pokhabov, A V Artemeva, Anna V Eremeeva, Yulia N Linkova, Arina V Zinkina-Orikhan
[Long-term efficacy and safety of divozilimab during 2-year treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 124 (4) (2024)
Alexey Boyko, K Z Bakhtiyarova, O V Boyko, V A Dudin, L G Zaslavsky, N A Malkova, Ye V Parshina, I Ye Poverennova, Stella Sivertseva, N A Totolyan, S G Shchur, F A Khabirov, Zoya A Goncharova, Maria Zakharova, D D Bolsun, Arina V Zinkina-Orikhan, Yulia N Linkova, T V Chernovskaya, A A Porozova
[Long-term Efficacy and Safety of Sampeginterferon-β1a in the Treatment of Relapsing Remitting Multiple Sclerosis: a Randomized, Double-Blind Clinical Trial 104-Week Results]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 123 (2) (2023)
A N Boyko, Valentina M Alifirova, I G Lukashevich, Zoya A Goncharova, I V Greshnova, L G Zaslavsky, S V Kotov, N A Malkova, G N Mishin, Ye V Parshina, I Ye Poverennova, L N Prakhova, Stella Sivertseva, I V Smagina, N A Totolyan, Yu V Trinitatsky, T N Trushnikova, F A Khabirov, Zh Yu Chefranova, S G Shchur, V A Dudin, D V Pokhabov, D D Bolsun, Anna V Eremeeva, Yulia N Linkova, Arina V Zinkina-Orikhan
[Efficacy and safety of antiCD20 monoclonal antibody divozilimab during 48-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 123 (7. Vyp. 2) (2023)
Alexey Boyko, K Z Bakhtiyarova, O V Boyko, V A Dudin, L G Zaslavsky, N A Malkova, Ye V Parshina, I Ye Poverennova, Stella Sivertseva, N A Totolyan, S G Shchur, F A Khabirov, Zoya A Goncharova, Maria Zakharova, D D Bolsun, Arina V Zinkina-Orikhan, Yulia N Linkova, T V Chernovskaya, A A Porozova
[Long-term Efficacy and Safety of Sampeginterferon-β1a in the Treatment of Relapsing Remitting Multiple Sclerosis: a Randomized, Double-Blind Clinical Trial 104-Week Results]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 123 (2) (2023)
A N Boyko, Valentina M Alifirova, I G Lukashevich, Zoya A Goncharova, I V Greshnova, L G Zaslavsky, S V Kotov, N A Malkova, G N Mishin, Ye V Parshina, I Ye Poverennova, L N Prakhova, Stella Sivertseva, I V Smagina, N A Totolyan, Yu V Trinitatsky, T N Trushnikova, F A Khabirov, S G Shchur, A V Artemeva, D D Bolsun, Arina V Zinkina-Orikhan, Yulia N Linkova
[Efficacy and safety of divozilimab during 24-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-2]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 123 (4) (2023)
A N Boyko, Valentina M Alifirova, I G Lukashevich, Zoya A Goncharova, I V Greshnova, L G Zaslavsky, S V Kotov, N A Malkova, G N Mishin, Ye V Parshina, I Ye Poverennova, L N Prakhova, Stella Sivertseva, I V Smagina, N A Totolyan, Yu V Trinitatsky, T N Trushnikova, F A Khabirov, S G Shchur, A V Artemeva, D D Bolsun, Arina V Zinkina-Orikhan, Yulia N Linkova
[Efficacy and safety of divozilimab during 24-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-2]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 123 (4) (2023)
A N Boyko, Valentina M Alifirova, I G Lukashevich, Zoya A Goncharova, I V Greshnova, L G Zaslavsky, S V Kotov, N A Malkova, G N Mishin, Ye V Parshina, I Ye Poverennova, L N Prakhova, Stella Sivertseva, I V Smagina, N A Totolyan, Yu V Trinitatsky, T N Trushnikova, F A Khabirov, S G Shchur, A V Artemeva, D D Bolsun, Arina V Zinkina-Orikhan, Yulia N Linkova
[Efficacy and safety of divozilimab during 24-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-2]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 123 (4) (2023)
A N Boyko, Valentina M Alifirova, I G Lukashevich, Zoya A Goncharova, I V Greshnova, L G Zaslavsky, S V Kotov, N A Malkova, G N Mishin, Ye V Parshina, I Ye Poverennova, L N Prakhova, Stella Sivertseva, I V Smagina, N A Totolyan, Yu V Trinitatsky, T N Trushnikova, F A Khabirov, S G Shchur, A V Artemeva, D D Bolsun, Arina V Zinkina-Orikhan, Yulia N Linkova
[Efficacy and safety of divozilimab during 24-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-2]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 123 (4) (2023)
Alexey Boyko, O V Boyko, K Z Bakhtiyarova, E I Gusev, V A Dudin, L G Zaslavsky, N A Malkova, Ye V Parshina, I Ye Poverennova, Stella Sivertseva, N A Totolyan, S G Shchur, A S Fedulov, F A Khabirov, D D Bolsun, Arina V Zinkina-Orikhan, Yulia N Linkova, T V Chernovskaya
[Efficacy and safety of sampeginterferon β-1a in the treatment of relapsing remitting multiple sclerosis: results of 52 weeks of therapy in a randomized, double-blind clinical trial]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 122 (1) (2022)
Yu D Minina, Alexander Zakharov, I Ye Poverennova, O V Androfagina
[Study of the effectiveness of neuroprotective therapy in restoring motor function in patients during the acute period of ischemic stroke]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 121 (9) (2021)
Sergey Burd, A V Lebedeva, N V Kukina, Yu V Rubleva, N V Pizova, S V Vasil'ev, A N Belova, O V Vorobieva, V V Emel'yanova, V A Zhadnov, N E Ivanova, V V Kalinin, M Ya Kissin, S V Kotov, N E Maksimova, V A Mihailov, A E Novikov, I Ye Poverennova, M A Yamin
[Clinical results and prospects for the use of phenosanic acid in patients with focal epilepsy]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 121 (10) (2021)